Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Cognex Sees Q3 Sales $245.000M-$265.000M vs $250.071M Est

Author: Benzinga Newsdesk | July 30, 2025 04:31pm
Cognex (NASDAQ:CGNX) sees Q3 sales of $245.000 million-$265.000 million vs $250.071 million analyst estimate.

Posted In: CGNX

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist